Send to

Choose Destination
Leuk Lymphoma. 2018 Jul;59(7):1565-1573. doi: 10.1080/10428194.2017.1370548. Epub 2017 Sep 7.

Regulation of MAPK signaling and implications in chronic lymphocytic leukemia.

Author information

a Sanford Burnham Prebys Medical Discovery Institute , La Jolla , CA , USA.
b La Jolla Institute for Allergy and Immunology , La Jolla , CA , USA.
c Department of Genetics Cell Biology and Anatomy , University of Nebraska Medical Centre , Omaha , NE , USA.


Chronic lymphocytic leukemia (CLL) is a heterogeneous B cell malignancy that still remains incurable. Recent studies have highlighted cellular and non-cellular components of the tissue microenvironment in CLL that help nurture the growth of leukemic cells by providing the necessary stimuli for their proliferation and survival. The diverse stimuli in the specialized tissue microenvironment of CLL lead to constitutive activation of several signaling pathways that includes B cell receptor signaling and the associated mitogen-activated protein kinase (MAPK) signaling. Recent findings have described aberrant activation of MAPK signaling and its interactions with other cellular signaling pathways in the pathogenesis of CLL. These studies have shed light on the deregulated molecular mechanisms contributing to hyperactivation of MAPK signaling and provided avenues for therapeutic options for aggressive CLL. In this review, we describe and discuss the current status of our understanding into the role of MAPK signaling in the pathogenesis of CLL.


BCR signaling; MAPK signaling; Word; chronic lymphocytic leukemia

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center